The SINEPOST study is linked with two national Public Health surveillance studies that are conducted through the National Perinatal Epidemiology Unit at the University of Oxford: the UK Obstetric Surveillance System-COVID-19 in pregnancy (UKOSS) study¹ and the British Paediatric Surveillance Unit- Neonatal Complications of Coronavirus Disease (BPSU) study².

Three cohorts of potential participants will be invited to take part in the SINEPOST study:

1. Mothers of infants who had SARS-CoV-2infection within 28 days after birth (neonatal exposure cohort)
2. Mothers who had SARS-CoV-2infection during pregnancy (antenatal exposure cohort)
3. Mothers who did not have SARS-CoV-2infection during pregnancy and their infants did not have SARS-CoV-2infection in the first 28 days after birth (comparison cohort)

References

1. National Perinatal Epidemiology Unit (NPEU), UK Obstetric Surveillance System (UKOSS) [website accessed 24th June 2021]

2. Royal College of Paediatrics and Child Health, BPSU study – Neonatal complications of coronavirus disease [website accessed 24th June 2021]